Long-term Efficacy of Satralizumab in AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar

Kleiter, I; Traboulsee, A; Palace, J; Yamamura, T; Fujihara, K; Saiz, A; Javed, A; Mayes, D; von Büdingen, HC; Klingelschmitt, G; Stokmaier, D; Bennett, JL

Kleiter, I (通讯作者)，Ruhr Univ Bochum, Bochum, Germany.;Kleiter, I (通讯作者)，Behandlungszentrum Kempfenhausen Multiple Sklerose, Marianne Str Klin, Berg, Germany.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023; 10 (1):

Abstract

Background and ObjectivesSatralizumab, an interleukin 6 receptor inhibitor, reduced the risk of protocol-defined relapse (PDR) vs placebo in 2 indepen......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索